🚨🚨 We are happy to share the latest news from our portfolio company, eGenesis, Inc., which recently raised a USD 191 million round to advance toward its first clinical trials after the company's genetically modified pig kidney was transplanted into a patient in a first for the xenotransplantation field. The funds will also be used to advance eGenesis's pipeline programs as well as scale production. The financing round was led by Lux Capital, with participation from existing investors Arch Ventures, Khosla Ventures, Farallon Capital Management, Alta Partners, Fresenius Medical Care Ventures, and Leaps by Bayer as well as new investors DaVita Kidney Care, Eisai Innovation Inc, NATCO Pharma , and Parkwood Corporation. 🔎 🔎 Read more about the news below 👇 WSJ ➡ https://lnkd.in/dMHT8h3S Axios ➡ https://lnkd.in/eYQKSGsB Boston Business Journal ➡ https://lnkd.in/d9cHXkf7 cc Christian Schütz Sabrina Stöckl
b2venture
Wagniskapital- und Private-Equity-Auftraggeber
b2venture (formerly btov Partners) is a European venture firm, leveraging the power of generations to shape tomorrow.
Info
Backing the Unique, the Mavericks, the Outliers b2venture (formerly btov Partners) is a European venture firm, leveraging the power of generations to shape tomorrow. We invest at the earliest stages in the best ideas and the brightest minds so they can take flight.
- Website
-
https://www.b2venture.vc/
Externer Link zu b2venture
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Sankt Gallen
- Art
- Privatunternehmen
- Gegründet
- 2000
- Spezialgebiete
- Venture Capital
Orte
-
Primär
Blumenaustrasse 36
Sankt Gallen, 9000, CH
-
Neue Schönhauser Straße 8
Berlin, 10178, DE
Beschäftigte von b2venture
Updates
-
🎉 🎉 We are pleased to welcome two new additions to the b2venture team! Selina Neumann joins the b2venture Direct Investments team as an Associate, coming to us from better ventures, where she worked with founders and angels, primarily focusing on the fields of ClimateTech, HealthTech, and EdTech. She studied International Business Administration at the WHU – Otto Beisheim School of Management and received her Master’s in Management at the University of Mannheim. “I enjoy working with founders driven to solve essential challenges for society and the environment. What drew me to b2venture was the opportunity to work with one of Europe’s most experienced angel communities, alongside b2venture’s dedicated funds, to invest in innovative tech start-ups and support businesses that can have an outsized impact on the world.” Valentin Wierse joins the b2venture Direct Investments team as an Analyst after stints at Accenture and HV Capital and works across our investment and finance teams to ensure smooth investing activity with our angel community. He studied Business Management and Economics at the University of Würzburg and received his Master of Science in Business Administration from Ludwig-Maximilians-Universität München. “The scale at which we work with our angel community is really unique in Europe, and it’s intensely gratifying to be able to learn from this group of seasoned entrepreneurs and investors and look at innovation across so many different industries and investment stages.” Both are based in Munich. Happy to have you both on board and look forward to backing the next generation of outlier companies in Europe and beyond!
-
-
📚 📓 ✏ 𝐖𝐡𝐚𝐭 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐭𝐡𝐞 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈 𝐨𝐧 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧? The speed at which #GenerativeAI is being adopted among students and educators is already having profound consequences on how we think about education, especially for the youngest students. Educators in K-12 will need to act fast to manage this technology and harness its promise for better student outcomes. Generative AI’s rapid adoption also presents outsized opportunities for startups to build solutions that can provide immediate and superior improvements to mainstream LLMs. As folks head back to school, b2venture’s Anna Bosch explores the opportunities for #EdTech startups and #GenAI, and lays out our investment hypotheses in her latest blogpost. 🔎 🔎 Read more at the b2venture website: https://lnkd.in/divHFvr2
-
-
Our portfolio company, DeepL, has made it onto the Forbes Cloud 100 list for the second year in a row, joining companies such as OpenAI and Anthropic and other AI leaders who are transforming technology as we know it. “Being named to the Forbes Cloud 100 list for two years in a row is a testament to DeepL’s steadfast commitment to research and innovation in the Language AI space. It also affirms the significant—and proven—impact that the DeepL platform is having on the way businesses around the world operate and grow.,” says DeepL founder and CEO Jaroslaw (Jarek) Kutylowski. 🔎 🔎 Read more from DeepL here ➡ https://lnkd.in/ds55CdVS 🔭 🔭 And read more about who else is on the list at Forbes ➡ https://lnkd.in/etRHGNfs
-
-
🚨🚨 Very excited to share the news that our portfolio company Urban Sports Club has acquired myClubs, the leading player for sports and wellness in the Austrian and Swiss markets. This acquisition is a big one for the European fitness market, creating the first full-service fitness offering across the entire DACH region. The integration of myClubs extensive network and expertise with Urban Sports Club's innovative approach and broad reach will provide unparalleled benefits to both corporate clients and individual consumers. Urban Sports Club has thereby reached an important milestone on their mission of getting people active and improving wellbeing in the workplace. Congratulations to Moritz and Benjamin and welcome Tobias! 🚀 🚀 Read more about the news at Handelsblatt below ⬇ https://lnkd.in/dq3w-Mws cc Jan-Hendrik Buerk Marisa Yasmin Krummrich
-
-
Are we on the cusp of a new era - a fourth wave of innovation in software businesses - with #GenAI? Don't miss b2venture's Andreas Goeldi in October at the ETH Zürich Zentrum Campus for some of his latest thoughts on how generative AI is reshaping the future.
Happy to announce that I will hold a workshop about generative AI business models at the upcoming LAUNCH conference organized by the ETH Entrepreneur Club and SICTIC. Please join me on October 18 for a discussion about how generative AI is going to change the future of software entrepreneurship. My recent post will give you an initial overview of the topic: https://lnkd.in/exzdiiTu Sign up for LAUNCH here: https://lnkd.in/exPeEvkp
-
-
𝗛𝗼𝘄 𝗰𝗮𝗻 𝗔𝗜 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗺𝗮𝗿𝗸𝗲𝘁𝘀? 🤖 💥 b2venture's Johanna Junkermann and Anna Bosch spoke recently with Jan Thomas from Startup Insider on their podcast series ‘Investments & Exits’, to analyse the latest financing rounds of EliseAI, an AI-powered tool for property management and sales, as well as trumpet 🎺 a startup offering a platform that bundles the entire buying process for sales teams in a centralised, collaborative workspace. "B2B sales is getting more and more complicated in terms of processes, documentation, technical specifications, and personas that sales teams need to reach, as well as a very fragmented and crowded tool landscape. That's why we are seeing a new wave of solutions that are attempting to optimize the entire sales process." 🎧 🎧 Listen to the podcast and hear their take on state of play in B2B sales software and how companies are leveraging AI at the link below ➡ https://lnkd.in/dcGnm5gj
-
-
𝗖𝗮𝗻 𝗔𝗜 𝗿𝗲𝗽𝗹𝗮𝗰𝗲 𝗩𝗖𝘀? b2venture Partner Andreas Goeldi has been asking this question for a while and is continuously probing the implications of generative AI and Large Language Models (LLMs) for venture investors and our workflows as a VC firm, which have profited enormously from Gen AI's capabilities. 🔎🔎 Gründerszene recently made his exploration of this question available in German for the first time ➡ ➡ https://lnkd.in/gqa5NUJv If you want to read his original post in English, then head over to the b2venture website 👇👇 https://lnkd.in/e4K7r_Eq
-
-
🔦 🔦 Job opportunity at our portfolio company Atlas Metrics, which is building the market-leading technology platform for organizations to track their Environmental, Social, and Governance (ESG) data and manage their sustainability performance. The company is looking for an experienced, motivated and detail-oriented Senior Finance Manager to built up their finance function as we scale rapidly. This role is ideal for someone with significant experience in strategic finance & accounting with exceptional analytical skills and a strong commercial acumen. 🔎 🔎 Read more about the position at Atlas Metrics here --> https://lnkd.in/dMg6vCB9 👀 👀 And have a look at the over 1000 other open positions available across the b2venture portfolio here --> https://lnkd.in/eGGrQKrc
-
-
📣 📣 On the heels of the news from our portfolio company Healx and their USD 47 million Series C round led by R42 Group and Atomico, with participation from ourselves and others, b2venture partner Gerrit Jurilj 🇺🇦 sat down with Jan Thomas from Startup Insider to discuss why Healx is so interesting for investors, the promise of AI in biotech, how patent regulations and market conditions affect the biotech industry, and the ethical considerations in the develop of drugs for rare diseases. Healx was founded in 2014 in Cambridge in the U.K. and uses AI to develop treatments for rare diseases and recently received approval for a test treatment for neurofibromatosis, a genetic disease that can lead to tumor formation. 🎧🎧 Listen to the entire podcast here ➡ https://lnkd.in/dEYKHNMu cc Sven Eppert Christian Schütz
-